Productivity
Can Nicotine Pouches Really Enhance Productivity?
Nicotine pouches may temporarily boost attention or reduce fatigue—but at a cost.
Updated January 5, 2026 Reviewed by Devon Frye
Key points
- Nicotine is a mild stimulant and has historically been used by institutions as a productivity enhancer.
- In many 20th-century workplaces, as well as the military, smoking was used to cope with stress and boredom.
- In a continuation of this trend, some modern workplaces now offer nicotine pouches to employees.
- However, nicotine is still addictive, even in pouch form, and prolonged use may negatively affect health.
Throughout history, nicotine has been used by the military and corporate America to enhance alertness and performance in the troops and workers. Recent reporting by the Wall Street Journal highlights a modern twist on this trend: Some technology companies are stocking free nicotine pouches in office refrigerators or vending machines, framed as an employee perk.
Workers using the pouches describe improved focus, reduced boredom, and a cognitive “edge” in hypercompetitive environments. Nicotine’s relatively short half-life compared with caffeine is frequently cited as an advantage, allowing stimulation without prolonged jitteriness or sleep disruption.
These startups position nicotine pouches as modern, clean, and controllable alternatives to other kinds of tobacco products, just as influencer-driven social-media content has reframed the pouches as “lifestyle accessories” rather than addictive drugs. However, the pharmacology and addictive properties of nicotine haven’t changed; only the delivery method has.
This trend raises the question: Can nicotine pouches, beyond reducing cigarette use, genuinely enhance work performance? The jury is still out on that question—and in the meantime, the other risks of nicotine use are well-established.
What Makes Nicotine Pouches Different?
Nicotine pouches are small, disposable microfiber packets containing nicotine powder, flavorings, and stabilizing agents. Some pouches use tobacco-derived nicotine, while others use laboratory-synthesized nicotine marketed as “tobacco-free” or “non-tobacco nicotine.”
The pouches are placed between the lip and gum, allowing nicotine to be absorbed through the oral mucosa. Unlike traditional smokeless tobacco, the substance many people associate with country characters in the old movie “Deliverance,” these pouches contain no tobacco leaf and, consequently, don’t require frequent spitting. Nicotine pouches deliver doses comparable to (or exceeding) those delivered by cigarettes or traditional smokeless tobacco.
From a harm-reduction standpoint, nicotine pouches are certainly safer than cigarettes. For one thing, there’s no smoke, as well as no second- or third-hand smoke—the toxic chemical residue from tobacco smoke clinging to furniture, walls, carpets, and clothing long after a cigarette is extinguished. For established smokers, then, switching to oral nicotine reduces their and others' exposure to combustion-related toxins and carcinogens, and some public-health authorities have cautiously endorsed pouches as a lower-risk alternative for smokers unable/unwilling to quit.
However, reduced harm is not equivalent to no harm, especially among adolescents and young adults, as well as occasional or non-smokers. Nicotine, no matter its form, is highly addictive, with well-documented cardiovascular, neurodevelopmental, and pregnancy-related risks.
Nicotine Pouch Prevalence: Adults Versus Youth
Current overall nicotine pouch use among U.S. adults remains relatively low. In 2024-2025, just 0.4 percent of adults—roughly 1 million people—reported use. This prevalence has been stable for several years, suggesting many users are ex-smokers or trying to stop smoking.
However, the pattern among youth and young adults differs and is arguably disturbing. University of Michigan's MMF data confirm that nicotine pouch use among U.S. adolescents has increased in recent years, particularly among high school students.
In 2020, nicotine pouches were largely absent from youth surveys because of minimal awareness, availability, and use. But surveys showed an apparent increase between 2023 and 2024 in both lifetime and current use, particularly among older adolescents and young adults in their early twenties. Measured prevalence remains relatively low compared with e-cigarettes, but trend data show increases in current and lifetime use, some suggesting doubling over short intervals.
The History of Nicotine as a Productivity Enhancer
Looking back to the late 19th century, nicotine was widely recognized as a mild stimulant, sharpening attention and reducing fatigue. Cigarettes fit seamlessly into the workplace, offering stimulation without intoxication or extended breaks. By the 1920s, tobacco advertising framed cigarettes as aids to alertness, emotional regulation, and productivity.
World War I globally institutionalized nicotine consumption, particularly in the military. Many in military leadership perceived tobacco as necessary for morale, endurance, and performance. Cigarettes were issued by the U.S., British, and French militaries, for example, and General John J. Pershing famously stated that tobacco was as necessary as bullets.
Recent surveys of U.S. military personnel show that nicotine pouch use far exceeds that of civilian adults. American soldiers are now 10 times more likely to use nicotine pouches than average Americans, according to a survey of military personnel.
“Military personnel historically use tobacco and nicotine products at much higher rates than their civilian counterparts,” said Melissa Little, Ph.D., director of the Center for Nicotine and Tobacco Research at the University of Virginia School of Medicine. “Our results show that these same disparities are continuing with new and emerging products, like nicotine pouches.”
The subsequent widespread distribution of cigarettes to factory workers post-WWI was a consequence of wartime production necessity, mass production, and cultural acceptance of smoking, with tobacco companies facilitating supply. The factory assembly line brought monotony, structured pacing, and limited autonomy. Cigarette breaks were brief, predictable, and did not disrupt operations, making them attractive from management’s perspective.
Long-term health consequences emerged later. But for decades, cigarettes were viewed as productivity aids—a perspective that shifted with accumulating health evidence after World War II. By the late 20th century, their role in the workplace had declined, prompting workplace restrictions and public health campaigns.
New Product, Same Old Nicotine
By eliminating smoke and combustion, nicotine pouches shed much of the stigma and exposure risks linked with cigarettes. But pharmacologically, nicotine remains a potent, addictive stimulant, increasing heart rate and blood pressure, and is still associated with cardiovascular risk even in non-combustible forms, such as the pouch delivery system.
Some employers may implicitly signal that nicotine initiation or use is compatible with performance. But dependence develops quickly, and withdrawal symptoms—irritability, dysphoria, impaired concentration—ultimately undermine productivity gains initially sought.
Patterns of escalation, frequent daily use, and difficulty stopping are all issues with nicotine pouches. While many research studies reported that pouches can be important harm-reduction tools for smokers, they also acknowledge that continued use represents ongoing nicotine dependence.
Nicotine Pouch Era
Nicotine pouches are helping smokers or vapers stop, reduce, or switch to tobacco-free nicotine pouches. Epidemiologic studies consistently raise concern about adolescent nicotine intake, given the heightened vulnerability of the developing brain to nicotine-induced neuroadaptation. The pouches' design features—including flavorings, discreet use, and marketing emphasizing cleanliness and modernity—may increase abuse potential, particularly among young and nicotine-naïve users.
Reports of nicotine pouches in technology offices aren’t innovation, then, but a novel take on a recurring institutional impulse: to chemicalize the limits of human attention rather than redesign the systems that strain it. Past experience shows us where this leads—to nicotine addiction.
References
Urban C, Yang KH, Palamar JJ. Nicotine and cannabis vaping-related workplace absenteeism among U.S. Adults, 2022. Addict Behav. 2025 Aug;167:108362. doi: 10.1016/j.addbeh.2025.108362. Epub 2025 Apr 19. PMID: 40253779; PMCID: PMC12160011.
Abid S, Aggarwal A, Duarte F, Sethi S, Iyengar S, Zarich S. Nicotine pouches and youth: emerging patterns and potential cardiovascular risks. Front Public Health. 2025 Nov 20;13:1632313. doi: 10.3389/fpubh.2025.1632313. PMID: 41358246; PMCID: PMC12675456.
Al-Otaibi HM, Althobiani MA. Nicotine pouches: a narrative review of the existing literature. Front Public Health. 2025 Aug 26;13:1641308. doi: 10.3389/fpubh.2025.1641308. PMID: 40933411; PMCID: PMC12417499.
Little MA, Polaskey KM, Pilehvari A, Krukowski RA, Ribisl KM, Pearce TD. Nicotine Pouch Use Among US Military Personnel. JAMA Netw Open. 2024;7(12):e2451517. doi:10.1001/jamanetworkopen.2024.51517
Ling PM, Hrywna M, Talbot EM, Lewis MJ. Tobacco-Derived Nicotine Pouch Brands and Marketing Messages on Internet and Traditional Media: Content Analysis. JMIR Form Res. 2023 Feb 15;7:e39146. doi: 10.2196/39146. PMID: 36790840; PMCID: PMC9978966.
Duan Z, Henriksen L, Vallone D, Rath JM, Evans WD, Romm KF, Wysota C, Berg CJ. Nicotine pouch marketing strategies in the USA: an analysis of Zyn, On! and Velo. Tob Control. 2024 Feb 20;33(2):154-163. doi: 10.1136/tc-2022-057360. PMID: 35817549; PMCID: PMC11827556.
Benowitz NL. Nicotine addiction. N Engl J Med. 2010 Jun 17;362(24):2295-303. doi: 10.1056/NEJMra0809890. PMID: 20554984; PMCID: PMC2928221.
Benowitz NL, Burbank AD. Cardiovascular toxicity of nicotine: Implications for electronic cigarette use. Trends Cardiovasc Med. 2016 Aug;26(6):515-23. doi: 10.1016/j.tcm.2016.03.001. Epub 2016 Mar 10. PMID: 27079891; PMCID: PMC4958544.
Pant S, Anderer S. Can Nicotine Pouches Help People Quit Smoking? JAMA. Published online January 02, 2026. doi:10.1001/jama.2025.22811